Skip to main content

UBS Group AG

Position in TCRX — TScan Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in TCRX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$32,807
-$22,391 QoQ
Shares Held
32,484
-41.2% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. TCRX ranks #411 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TCRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $32,807 32,484
2025-12-31 $55,198 55,198
2025-09-30 $20,152 11,073
2025-06-30 $580,581 400,401
2025-03-31 $170,348 123,441
2024-12-31 $279,254 91,860
2024-09-30 $96,333 19,344
2024-06-30 $73,973 12,645
2024-03-31 $15,093 1,901
2023-12-31 $8,301 1,424
2023-09-30 $2,854 1,115
2023-06-30 $2,750 1,100
2023-03-31 $6,804 3,240
2022-12-31 $1,550 1,000
2022-09-30 $10,495 3,441
2022-06-30 $3,610 1,148
2021-12-31 $3,649 811
2021-09-30 $7,889 946